Experimental strategy to identify genes susceptible to oxidative stress in nigral dopaminergic neurons

Neurochemical Research

Volumn 29, Issue 6, 2004, Pages 1223-1234

  Yoo, Myung S ^a   Kawamata, Hibiki ^a   Kim, Dae J ^a   Chun, Hong S ^a,b   Son, Jin H ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Chosun University   (South Korea)

^c BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Dopaminergic neuron; Mitochondrial complex I; Neuroprotection; Oxidative stress; Parkinson's disease; siRNA

Indexed keywords

COMPLEMENTARY DNA; PROTEASOME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); DOPAMINE; NERVE PROTEIN;

ANIMAL CELL; BRAIN TISSUE; CELL CULTURE; CELL DEATH; CELL LINE; CONTROLLED STUDY; DILUTION; DNA MICROARRAY; DOPAMINERGIC NERVE CELL; EMBRYO; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; MITOCHONDRION; MOLECULAR CLONING; MOUSE; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SUBSTANTIA NIGRA; VALIDATION PROCESS; ARTICLE; BIOLOGICAL MODEL; GENETICS; HUMAN; MOLECULAR GENETICS; NERVE CELL; PHYSIOLOGY;

ANIMALIA;

CELL LINE; DOPAMINE; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; OXIDATIVE STRESS; SUBSTANTIA NIGRA;

EID: 3142676334     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000023609.08038.c3     Document Type: Review

References (46)

1. Son, J. H., Chun, H. S., Joh, T. H., Cho, S., Conti, B., and Lee, J. 1999. Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J. Neurosci. 19:10-20.
2. +, oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76:1010-1021.
3. Yoo, M. S., Chun, H. S., Son, J. J., DeGiorgio, L. A., Kim, D. J., Peng, C., Son, J. H. 2003. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Mol. Brain Res. 110:76-84.
4. Langston, J. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. 1998. Ann. Neurol. 44(Suppl. 1):S45-S52.
5. Tanner, C., Ottman, R., Goldman, S., Ellenberg, J., Chan, P., Mayeux, R., and Langston, J. 1999. Parkinson's disease in twins: an etiologic study. JAMA 281:341-346.
6. Olanow, C. W. and Tatton, W. G. 1999. Etiology and pathogenesis of Parkinson's disease. Ann. Rev. Neurosci. 22:123-144.
7. Chan, P., Jiang, X., Forno, L., DiMonte, D., Tanner, C. and Langston, J. 1998. Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease. Neurology 50:1136-1137.
8. Fahn, S. and Cohen, G. 1992. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32:804-812.
9. Jenner, P. and Olanow, C. W. 1998. Understanding cell death in Parkinson's disease. Ann. Neurol. 44(Suppl. 1):S72-84.
10. Jenner, P. 2003. Oxidative stress in Parkinson's disease. Ann. Neurol. 53(Suppl. 3):S26-36.
11. Coyle, J. T. and Puttfarcken, P. 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695.
12. Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P. and Marsden, C. D. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381-389.
13. Dexter, D. T., Holley, A. E., Flitter, W. D., Slater, T. F., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P. and Marsden, C. D. 1994. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9:92-97.
14. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., and Mizuno, Y. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:2696-2701.
15. Zhang, J., Perry, G., Smith, M. A., Robertson, D., Olson, S. J., Graham, D. G., Montine T. J. 1999. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 154:1423-1429.
16. Alam, Z. I., Jenner, A. Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P, Halliwell B. 1997. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69:1196-1203.
17. Sriram, K., Pai, K. S., Boyd, M. R., and Ravindranath, V. 1997. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res. 749:44-52.
18. Zou, L., Xu, J., Jankovic, J., He, Y., Appel, S. H., and Le, W., 2000. Pramipexole inhibits lipid peroxidation and reduces injury in the substantia nigra induced by the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine in C57BL/6 mice. Neurosci. Lett. 281:167-170.
19. Matthews, R. T., Klivenyi, P., Muller, G., Yang, L., Wermer, M., Thomas, C. E., Beal, M. F. 1999. Novel free radical spin traps protect against malonate and MPTP neurotoxicity. Exp. Neurol. 157:120-126.
20. Kumar, R., Agarwal, A. K., and Seth, P. K. 1995. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 64:1703-1707.
21. Perumal, A. S., Gopal, V. B., Tordzro, W. K., Cooper, T. B., and Cadet, J. L. 1992. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res. Bull. 29:699-701.
22. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease, Nat. Neurosci. 3:1301-1306.
23. Sherer, T. B., Betarbet, R., Stout, A. K., Lund, S., Baptista, M., Panov, A. V., Cookson, M. R., Greenamyre, J. T. 2002. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 22:7006-7015.
24. Tatton, N., Maclean-Fraser, A, Tatton, W., Perl, D. and Olanow, C. 1998. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann. Neurol. 44:S142-S148.
25. Hunot, S., Brugg, Ricard, D., Michel, P., Muriel, M., Ruberg, M., Faucheux, B., and Agid, Y. 1997. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson's disease. Proc. Natl. Acad. Sci. USA. 94:7531-7536.
26. Lotharius, J., Dugan, L., and O'Malley, K. 1999. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19:1284-1293.
27. Oo, T., Henchcliffe, C., James, D., and Burke, R. 1999. Expression of c-fos, c-jun and c-jun N-terminal kinase (JNK) in a developmental model of induced apoptotic death in neurons of the substantia nigra. J. Neurochem. 72:557-564.
28. Brown, P. O. and Botstein, D. 1999. Exploring the new world of the genome with DNA microarrays. Nat Genet. 21(Suppl.):33-37.
29. Schena, M., Shalon, D., Davis, R. W., and Brown, P. O. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470.
30. Min, N., Joh, T. H., Kim, K. S., Peng, C., and Son, J. H. 1994. 5′ upstream DNA sequence of the rat tyrosine hydroxylase gene directs high-level and tissue-specific expression to catecholaminergic neurons in the central nervous system of transgenic mice. Mol. Brain Res. 27:281-289.
31. McNaught, K. S., Belizaire, R., Isacson, O., Jenner, P., and Olanow, C. W. 2003. Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179:38-46.
32. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K. and Tuschl, T. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
33. Chun, H. S., Lee, H., and Son, J. H. 2001. Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741. Neurosci. Lett. 316:5-8.
34. Perry, T. L., Godin, D. V., and Hansen, S. 1982. Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:305-310.
35. Perry, T. L. and Yong, V. W. 1986. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67:269-274.
36. Schapira, A. H., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., and Marsden, C. D. 1990. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:823-827.
37. Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., Sato, T., Oya, H., Ozawa, T., and Kagawa, Y. 1989. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163:1450-1455.
38. Burke, R. E. and Kholodilov, N. G. 1998. Programmed cell death: does it play a role in Parkinson's disease? Ann. Neurol. 44(Suppl. 1):S126-133.
39. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., and Takahashi. R. 2001. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105:891-902.
40. Gerlach, M. and Riederer, P. 1996. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J. Neural. Transm. 103:987-1041.
41. Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., and Greenamyre, J. T. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3:1301-1306.
42. Schapira, A. H., Gu, M., Taanman, J. W., Tabrizi, S. J., Seaton, T., Cleeter, M., and Cooper, J. M. 1998. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann. Neurol. 44(Suppl 1):S89-98.
43. Smeitink, J., Loeffen, J., Smeets, R., Triepels, R., Ruitenbeek, W., Trijbels, F., and van den Heuvel, L. 1998. Molecular characterization and mutational analysis of the human B17 subunit of the mitochondrial respiratory chain complex I. Hum. Genet. 103:245-250.
44. Ramanathan, M., Hassanain, M., Levitt, M., Seth, A., Tolman, J. S., Fried, V. A., and Ingoglia, N. A. 1999. Oxidative stress increases ubiquitin - protein conjugates in synaptosomes. Neuroreport 10: 3797-3802.
45. Shang, F., Gong, X., and Taylor, A. 1997. Activity of ubiquitin-dependent pathway in response to oxidative stress. Ubiquitin-activating enzyme is transiently up-regulated. J. Biol. Chem. 272:23086-23093.
46. Baumeister, W., Walz, J., Zuhl, F., and Seemuller, E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-380.